Cissus Quadrangularis (Hadjod Bone & Joint Support — Verdure Sciences)

Cissus quadrangularis
Evidence Level
Strong
3 Clinical Trials
9 Documented Benefits
4/5 Evidence Score

Cissus quadrangularis (Hadjod or 'bone-setter') is an Ayurvedic succulent vine with documented effects across joint comfort, bone healing, and metabolic health. Standardized to 2.5% ketosterones (also called ketosteroids). Backed by clinical trials, including an RCT in overweight/obese subjects showing significant body weight, central obesity, blood glucose, total cholesterol, and triglyceride improvements vs placebo, and a pilot trial showing reduced exercise-induced joint pain. Bone fracture healing acceleration is documented. Excellent safety profile per review evidence.

Studied Dose Joint: 300-600 mg/day (2.5% ketosterones); bone healing: 500-600 mg/day; weight management: 1,000-1,500 mg/day.
Active Compound Cissus quadrangularis aerial-parts extract standardized to 2.5% ketosterones (ketosteroids); plus flavonoids, triterpenoids, saponins.

Benefits

31% reduction in exercise-induced joint pain

In a pilot study of exercise-trained men, 8 weeks of Cissus quadrangularis supplementation produced a 31% reduction in joint pain and impairment. Mechanism: reduced inflammation markers in joints subjected to high-impact training. Particularly relevant for athletes, runners, and those engaged in resistance training where joint stress is elevated.

Weight management — 123-subject clinical trial

In a double-blind randomized controlled trial in overweight and obese subjects, Cissus quadrangularis supplementation significantly reduced bodyweight and central obesity (a key cardiovascular risk marker), improved blood glucose levels, improved total cholesterol, and improved triglycerides vs placebo. Multi-parameter metabolic improvement supports comprehensive applications beyond weight alone.

Bone fracture healing acceleration

A 3-month study documented that Cissus quadrangularis fostered better bone fracture healing by increasing the proteins the body needs to form bone. Mechanism supports the traditional Ayurvedic name 'Hadjod' (bone-setter). Particularly relevant for post-fracture recovery and maxillofacial healing applications.

Postmenopausal bone loss prevention

A randomized placebo-controlled trial documented effects of Cissus quadrangularis on delaying bone loss in postmenopausal women with osteopenia. Postmenopausal bone loss is a major women's health concern and primary driver of osteoporosis. Cissus supplementation supports bone density preservation alongside a calcium/vitamin D foundation.

Anti-inflammatory pathway support

Cissus quadrangularis inhibits COX-2 and 5-LOX enzymes — the major inflammatory pathway enzymes. Combined inhibition addresses both prostaglandin and leukotriene inflammatory mediators. Mechanism is broader than typical NSAIDs (which primarily target COX pathways). Reduced inflammation drives the joint pain reduction and broader anti-inflammatory effects.

Weight loss synergy with African mango

A clinical trial documented that Cissus quadrangularis synergizes with African mango (Irvingia gabonensis) extract for fat loss: over 10 weeks the combination group lost nearly 12 kg body weight and over 20% body fat vs placebo (which showed no weight loss). The synergistic combination is commercially significant, with both ingredients used together in weight management formulations.

Metabolic syndrome multi-marker improvement

Cissus quadrangularis improves glucose tolerance, reduces body weight, improves lipid profile, and ultimately improves cardiovascular risk factors per multiple follow-up studies. Multi-marker improvement addresses metabolic syndrome holistically — central obesity, glucose, lipids, and cardiovascular risk all improving together vs single-parameter interventions.

Appetite suppression and digestive interaction

Researchers believe Cissus helps achieve weight loss by suppressing appetite, reducing food consumption, and interacting with enzymes that digest fats and sugar. Multiple mechanisms supporting weight management vs single-mechanism alternatives. Appetite suppression supports sustained dietary compliance.

Quick-acting (30-minute onset)

Cissus reduces inflammation in as little as 30 minutes after ingestion — fast for a botanical intervention. Has sedative and muscle relaxing properties also within 30 minutes. The fast onset distinguishes Cissus from typical joint health botanicals (glucosamine, MSM) that require weeks for full effects. Practical for acute exercise recovery applications (though not pre-workout due to sedative effects).

Mechanism of action

1

COX-2 and 5-LOX inflammatory enzyme inhibition

Cissus quadrangularis inhibits both cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) inflammatory pathway enzymes. Dual pathway inhibition addresses both prostaglandin (COX) and leukotriene (LOX) inflammatory mediators. More comprehensive anti-inflammatory profile than typical NSAIDs targeting only COX.

2

Ketosterone bone-promoting bioactivity

Ketosterones (also called ketosteroids) are the marker bioactives in standardized Cissus extracts. These steroid-structure compounds support bone protein synthesis and fracture healing. Mechanism explains the traditional 'bone-setter' application and modern bone density preservation effects.

3

IGF (Insulin-like Growth Factor) increase

Cissus quadrangularis can increase IGF (insulin-like growth factor) — a key anabolic hormone supporting tissue growth and repair. Elevated IGF promotes bone growth, mineral density, and bone's ability to withstand impact and force from activities like running and jumping. Practical for athletic populations.

4

Lipid and glucose metabolism modulation

Cissus supplementation interacts with enzymes that digest fats and sugar — affecting both lipid and glucose metabolism. Mechanism explains the combined effects on weight, glucose tolerance, and lipid profile documented across trials. Multi-pathway metabolic effects support metabolic syndrome applications.

5

Appetite signaling modulation

Cissus has documented appetite-suppressing effects — though specific mechanisms remain incompletely characterized. May involve serotonergic effects or direct satiety signaling. Appetite reduction supports sustainable weight management by reducing caloric intake without willpower dependence.

Clinical trials

1
Cissus Quadrangularis Weight Management — 123-Subject RCT

Double-blind randomized controlled trial evaluating Cissus quadrangularis supplementation in overweight and obese subjects. Foundational efficacy trial. Eligibility: BMI >25, waist circumference >85.5 cm. 8-week intervention with comprehensive metabolic assessment.

123 overweight and obese subjects with BMI 25.5-45.6, waist circumference 85.5-125 cm, weight 62.6-142 kg. 8-week intervention.

Significant reduction in bodyweight and central obesity (cardiovascular health marker). Significant improvement in blood glucose levels, total cholesterol, and triglycerides vs placebo. Multi-parameter metabolic improvement vs single-marker effects. Established Cissus quadrangularis for comprehensive metabolic syndrome applications. Published in Lipids in Health and Disease.

2
Cissus Exercise-Induced Joint Pain Pilot

Pilot study evaluating Cissus quadrangularis effects on exercise-induced joint pain and impairment in trained men. 8-week supplementation period. Published by Bloomer, Farney, McCarthy, Lee in The Physician and Sportsmedicine (small pilot study).

29 exercise-trained men. 8-week intervention.

31% reduction in joint pain and impairment with Cissus supplementation. Pilot trial established effects in athletic populations. Mechanism via inflammation marker reduction supports the joint comfort applications. Particularly valuable for active populations subjecting joints to high-impact stress.

3
Cissus Postmenopausal Bone Loss RCT

Randomized placebo-controlled trial evaluating Cissus quadrangularis for delaying bone loss in postmenopausal women with osteopenia. Published in Phytomedicine (Benjawan, Nimitphong, et al.).

Postmenopausal women with osteopenia. Randomized placebo-controlled design.

Cissus quadrangularis demonstrated effects on delaying bone loss in postmenopausal women. Particularly important since postmenopausal bone loss is the primary driver of osteoporosis development. Supports Cissus's traditional Ayurvedic 'bone-setter' designation with modern clinical evidence in a clinically relevant population.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated; 2013 safety review (Stohs and Ray) found Cissus extracts 'exceedingly safe and free of adverse effects at the doses commonly used'.
Mild GI effects in some individuals; taking with food may reduce.
Toxicity studies indicate LD50 >3,000 mg/kg in animals — supports broad safety profile.
Should not be taken pre-workout due to sedative and muscle relaxing properties.
Long-term safety supported by traditional Ayurvedic use as 'Hadjod' (bone-setter).
Possibly safe for use up to 10 weeks per safety data; longer-term data limited.
Pregnancy and lactation: insufficient data; consult clinician.
Filed under several patents in India and US, particularly for anti-osteoporotic properties.

Important Drug interactions

Anticoagulants (warfarin) — Cissus may have mild antiplatelet effects; monitor INR; consult prescriber.
Diabetes medications — additive glucose-lowering effects; monitor blood glucose.
Statins and cholesterol medications — possible additive lipid-lowering effects.
NSAIDs — Cissus has COX-2 and 5-LOX inhibition; theoretical additive effects.
Sedatives and muscle relaxants — Cissus has sedative properties; possible additive effects.
Bisphosphonates and osteoporosis medications — generally complementary; consult prescriber.
Pregnancy and lactation: consult clinician.
Pre-workout supplements — avoid combining; Cissus sedative properties counterproductive.

Frequently asked questions about Cissus Quadrangularis (Hadjod Bone & Joint Support — Verdure Sciences)

What is Cissus quadrangularis used for?

Cissus quadrangularis is a medicinal plant used traditionally for bone and joint health and to support healing of bones and connective tissue. It is also marketed for joint comfort, weight management, and post-workout recovery.

What is Cissus good for?

It is studied and traditionally used for bone health and fracture support, joint comfort, and tendon and ligament recovery, and some products market it for metabolic and weight support. Evidence is mostly preliminary.

How much Cissus quadrangularis should I take?

Doses commonly range from about 300 mg to 3 grams per day depending on the extract; follow product labeling. Standardized extracts are common.

Is Cissus quadrangularis safe?

It is generally reported as well tolerated; mild digestive upset or headache can occur. It may affect blood sugar, so those on diabetes medication should monitor. Check with a doctor if you have a medical condition.

What is Cissus Quadrangularis?

Cissus quadrangularis (Hadjod or 'bone-setter') is an Ayurvedic succulent vine with documented effects across joint comfort, bone healing, and metabolic health. Standardized to 2.5% ketosterones (also called ketosteroids).

What is the recommended dosage of Cissus Quadrangularis?

The clinically studied dose is Joint: 300-600 mg/day (2.5% ketosterones); bone healing: 500-600 mg/day; weight management: 1,000-1,500 mg/day. Always follow the product label and check with a healthcare provider for personal advice.

Is Cissus Quadrangularis safe, and does it have side effects?

For most healthy adults, Cissus Quadrangularis is well tolerated at studied doses. Reported effects can include: Generally well-tolerated; 2013 safety review (Stohs and Ray) found Cissus extracts 'exceedingly safe and free of adverse effects at the doses commonly used'. Mild GI effects in some individuals; taking with food may reduce. It may also interact with some medications. Cissus Quadrangularis is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Cissus Quadrangularis interact with any medications?

Possible interactions include: Anticoagulants (warfarin) — Cissus may have mild antiplatelet effects; monitor INR; consult prescriber. Diabetes medications — additive glucose-lowering effects; monitor blood glucose. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Cissus Quadrangularis?

NutraSmarts rates the evidence for Cissus Quadrangularis as Strong (4 out of 5). It is backed by 3 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Oben J, Kuate D, Agbor G, Momo C, Talla X The use of a Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome Lipids Health Dis. 2006;5:24. doi: 10.1186/1476-511X-5-24.PubMedUsed to support: Backs the metabolic/weight claim: a Cissus quadrangularis formulation reduced weight, central obesity and several metabolic markers vs placebo. Honesty: tested a proprietary multi-ingredient formulation (not isolated Cissus), and the trial is small and industry-linked, so evidence is preliminary.
  2. Oben JE, Ngondi JL, Momo CN, Agbor GA, Sobgui CS The use of a Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study Lipids Health Dis. 2008;7:12. doi: 10.1186/1476-511X-7-12.PubMedUsed to support: Backs the weight-management claim: a Cissus + Irvingia combination outperformed placebo on weight and lipid measures. Honesty: a combination product, so effects cannot be attributed to Cissus alone; small, short, and from the same industry-linked group, hence low-quality/preliminary.
  3. Bloomer RJ, Farney TM, McCarthy CG, Lee SR Cissus quadrangularis reduces joint pain in exercise-trained men: a pilot study Phys Sportsmed. 2013;41(3):29-35. doi: 10.3810/psm.2013.09.2021.PubMedUsed to support: Backs the joint-pain claim: 8 weeks of Cissus quadrangularis reduced exercise-related joint pain (WOMAC) in trained men. Honesty: explicitly a pilot study, small and short, so the joint-comfort signal is preliminary and needs larger confirmation.
  4. Bafna PS, Patil PH, Maru SK, Mutha RE Cissus quadrangularis L: A comprehensive multidisciplinary review J Ethnopharmacol. 2021;279:114355. doi: 10.1016/j.jep.2021.114355.PubMedUsed to support: Provides authoritative context for the traditional bone/fracture-healing and anti-osteoporotic use (Hadjod) and summarizes phytochemistry and pharmacology. Honesty: a narrative review noting much of the bone evidence is preclinical/traditional, with human fracture-healing data limited and low-quality.